NEW YORK (360Dx) – Optrascan today announced its whole-slide scanners have received CE marking for in vitro diagnostic use in the European Union.

The company's on-demand desktop scanning systems are cloud-enabled and have small footprints, as well as low and high throughputs. In a statement, Optrascan Founder and CEO Abhi Gholap called the CE designation a "significant milestone" for the company "to support pathologists for the European continent toward adopting digital pathology for their requirements."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.